This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jack E. Riggs, MD
Department of Neurology West Virginia University Medical Center Morgantown, WV 26506

Arch Neurol. 1988;45(8):830.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—George Hoyt Whipple, Nobel Laureate and founding Dean of the University of Rochester (NY) School of Medicine and Dentistry, reported the initial description of intestinal lipodystrophy in 1907.¹ Chronic diarrhea with steatorrhea, weight loss, abdominal pain, lymphadenopathy, arthritis, and constitutional symptoms such as fever and weakness are frequent clinical features. The pathologic hallmark of the disorder is the presence of periodic acid-Schiff-positive rods and sickle-shaped inclusions in macrophages, which, by electron microscopy, are bacilliform particles. Neurologic manifestations occur in at least 10% of patients and include alterations of mental function with dementia, abnormalities of eye movement reflecting midbrain involvement, sleep disturbance, impotence, polydipsia and polyphagia reflecting hypothalamic involvement, seizures, meningoencephalitis, myelopathy, ataxia, and myoclonus. The etiopathogenesis of Whipple's disease remains incompletely defined, although an infectious process is implicated in part because bacilliform structures have been seen by electron microscopy and the response to antibiotics.² . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?